Application Nr Approved Date Route Status External Links
ANDA203293 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Memantine Hydrochloride Extended-Release Capsules Are An Nmda Receptor Antagonist Indicated For The Treatment Of Moderate To Severe Dementia Of The Alzheimer's Type. ( 1 ) Memantine Hydrochloride Extended-Release Capsules Are Indicated For The Treatment Of Moderate To Severe Dementia Of The Alzheimer's Type.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Memantine Hydrochloride MEMANTINE HYDROCHLORIDE ZINC100003200

Comments